Literature DB >> 11846415

Ablation of cellular prion protein expression affects mitochondrial numbers and morphology.

Gino Miele1, Martin Jeffrey, Doug Turnbull, Jean Manson, Michael Clinton.   

Abstract

The cellular prion protein (PrP(C)), predominantly expressed in the central nervous system, is required for pathogenesis of prion neurodegenerative diseases and its conversion into a pathogenic isoform (PrP(Sc)) is a common feature of disease. While the physiological function of PrP(C) remains unclear, accumulating evidence indicates a role for PrP(C) in oxidative homeostasis in vivo and suggests that PrP(C) may be involved in the cellular response to oxidative stress. Mice in which PrP(C) expression has been ablated are viable and develop normally. Here we show that in an inbred line of mice, in tissues that normally express PrP at moderate to high levels, ablation of PrP(C) results in reduced mitochondrial numbers, unusual mitochondrial morphology, and elevated levels of mitochondrial manganese-dependent superoxide dismutase antioxidant enzyme. These observations may have relevance to the pathogenic mechanism for this group of fatal neurodegenerative conditions. ©2002 Elsevier Science (USA).

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11846415     DOI: 10.1006/bbrc.2002.6460

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  19 in total

1.  Cellular prion protein is present in mitochondria of healthy mice.

Authors:  Robert Faris; Roger A Moore; Anne Ward; Brent Race; David W Dorward; Jason R Hollister; Elizabeth R Fischer; Suzette A Priola
Journal:  Sci Rep       Date:  2017-02-02       Impact factor: 4.379

Review 2.  New molecular insights into cellular survival and stress responses: neuroprotective role of cellular prion protein (PrPC).

Authors:  Raymond Yen-Yu Lo; Woei-Cherng Shyu; Shinn-Zong Lin; Hsiao-Jung Wang; Shun-Sheng Chen; Hung Li
Journal:  Mol Neurobiol       Date:  2007-06       Impact factor: 5.590

3.  Morphological and functional abnormalities in mitochondria associated with synaptic degeneration in prion disease.

Authors:  Zuzana Sisková; Don Joseph Mahad; Carianne Pudney; Graham Campbell; Mark Cadogan; Ayodeji Asuni; Vincent O'Connor; Victor Hugh Perry
Journal:  Am J Pathol       Date:  2010-07-22       Impact factor: 4.307

Review 4.  The multiple functions of PrPC in physiological, cancer, and neurodegenerative contexts.

Authors:  Izabella Grimaldi; Felipe Saceanu Leser; José Marcos Janeiro; Bárbara Gomes da Rosa; Ana Clara Campanelli; Luciana Romão; Flavia Regina Souza Lima
Journal:  J Mol Med (Berl)       Date:  2022-09-03       Impact factor: 5.606

5.  Embryonic activation and developmental expression of the murine prion protein gene.

Authors:  G Miele; A R Alejo Blanco; H Baybutt; S Horvat; J Manson; M Clinton
Journal:  Gene Expr       Date:  2003

6.  The prion protein knockout mouse: a phenotype under challenge.

Authors:  Andrew D Steele; Susan Lindquist; Adriano Aguzzi
Journal:  Prion       Date:  2007-04-25       Impact factor: 3.931

Review 7.  Mitochondrial dysfunction in neurodegenerative diseases associated with copper imbalance.

Authors:  Luisa Rossi; Marco F Lombardo; Maria R Ciriolo; Giuseppe Rotilio
Journal:  Neurochem Res       Date:  2004-03       Impact factor: 3.996

8.  An atlas of bovine gene expression reveals novel distinctive tissue characteristics and evidence for improving genome annotation.

Authors:  Gregory P Harhay; Timothy Pl Smith; Leeson J Alexander; Christian D Haudenschild; John W Keele; Lakshmi K Matukumalli; Steven G Schroeder; Curtis P Van Tassell; Cathy R Gresham; Susan M Bridges; Shane C Burgess; Tad S Sonstegard
Journal:  Genome Biol       Date:  2010-10-20       Impact factor: 13.583

Review 9.  Antioxidant and Metal Chelation-Based Therapies in the Treatment of Prion Disease.

Authors:  Marcus W Brazier; Anthony G Wedd; Steven J Collins
Journal:  Antioxidants (Basel)       Date:  2014-04-21

10.  Prion protein self-peptides modulate prion interactions and conversion.

Authors:  Alan Rigter; Jan Priem; Drophatie Timmers-Parohi; Jan P M Langeveld; Fred G van Zijderveld; Alex Bossers
Journal:  BMC Biochem       Date:  2009-11-30       Impact factor: 4.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.